Medial temporal tau predicts memory decline in cognitively unimpaired elderly

Alzheimer’s disease can be detected in living people using in vivo biomarkers of amyloid-β and tau, even in the absence of cognitive impairment during the preclinical phase. [(18)F]-MK-6420 is a high-affinity PET tracer that quantifies tau neurofibrillary tangles, but its ability to predict cognitiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwan, Angela T H, Arfaie, Saman, Therriault, Joseph, Azizi, Zahra, Lussier, Firoza Z, Tissot, Cecile, Chamoun, Mira, Bezgin, Gleb, Servaes, Stijn, Stevenon, Jenna, Rahmouni, Nesrine, Pallen, Vanessa, Gauthier, Serge, Rosa-Neto, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814120/
https://www.ncbi.nlm.nih.gov/pubmed/36627889
http://dx.doi.org/10.1093/braincomms/fcac325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814120/
https://www.ncbi.nlm.nih.gov/pubmed/36627889
http://dx.doi.org/10.1093/braincomms/fcac325

Ejemplares similares